Amicus Therapeutics, Inc. (FOLD)

Amicus Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	2,918	4,161	3,430	3,218	6,017	2,482
Market Cap Growth	10.98%	21.30%	6.59%	-46.51%	142.44%	36.86%
Enterprise Value	3,122	4,320	3,589	3,176	5,975	2,239
PE Ratio	-	-27.45	-14.50	-12.85	-21.73	-6.96
PS Ratio	6.89	10.42	10.42	10.53	23.06	13.62
PB Ratio	22.32	25.98	27.88	10.47	21.01	5.21
P/FCF Ratio	-39.53	-54.37	-20.55	-15.59	-25.44	-9.18
P/OCF Ratio	-43.11	-60.23	-20.59	-15.89	-25.79	-9.91
EV/Sales Ratio	7.37	10.82	10.90	10.40	22.90	12.29
EV/EBITDA Ratio	-45.51	-46.92	-17.98	-15.65	-24.59	-6.74
EV/EBIT Ratio	-41.06	-43.22	-17.51	-15.19	-23.73	-6.64
EV/FCF Ratio	-41.86	-56.45	-21.50	-15.39	-25.26	-8.28
Debt / Equity Ratio	3.40	2.78	3.67	1.43	1.54	0.44
Debt / EBITDA Ratio	-5.49	-4.83	-2.27	-2.17	-1.82	-0.63
Debt / FCF Ratio	-5.05	-5.82	-2.71	-2.13	-1.87	-0.78
Quick Ratio	2.22	2.23	2.59	3.67	4.09	3.77
Current Ratio	3.04	2.88	3.05	4.09	4.47	4.04
Asset Turnover	0.57	0.54	0.42	0.35	0.32	0.21
Interest Coverage	-1.77	-1.99	-5.52	-6.44	-11.23	-17.86
Return on Equity (ROE)	-109.80%	-119.50%	-141.70%	-87.20%	-80.80%	-68.70%
Return on Assets (ROA)	-19.60%	-20.40%	-30.40%	-29.00%	-34.30%	-41.70%
Return on Capital (ROIC)	-12.16%	-12.33%	-36.69%	-26.75%	-33.49%	-43.80%
Earnings Yield	-5.04%	-3.64%	-6.90%	-7.78%	-4.60%	-14.36%
FCF Yield	-3.02%	-1.84%	-4.87%	-6.41%	-3.93%	-10.90%
Buyback Yield / Dilution	-3.97%	-2.11%	-6.50%	-4.85%	-7.67%	-29.40%
Total Shareholder Return	-3.97%	-2.11%	-6.50%	-4.85%	-7.67%	-29.40%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).